Innvervace develops regenerative therapy solutions for neurodegenerative disorders.
Business Model:
Revenue: $0
Employees: 0-0
Address: 345 Park Avenue South
City: New York
State: NY
Zip: 10010
Country: US
Innervace is a developer of a regenerative therapy company designed to develop implantable tissue-engineered brain pathways for neurodegenerative disorders. The company is focused on the development and commercialization of anatomically inspired living scaffolds for brain pathway reconstruction, and its lead clinical product is a tissue-engineered nigrostriatal pathway that mimics the lost nigrostriatal pathway in patients with Parkinson&s;s disease. This gives patients access to technology that specifically reconstructs brain pathways rather than just masking symptoms temporarily. Innervace was established in 2018 by in Philadelphia, Pennsylvania
Contact Phone:
+12023527637
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Series A | 5 | $40M |
BioAdvance Deerfield IP Group Penn Medicine WARF Ventures Penn Medicine Co-Investment Program BioAdvance Deerfield IP Group Penn Medicine WARF Ventures |
8/2022 | Series A | $40M |
Deerfield Capital Management IP Group, Inc Penn Medicine WARF Ventures BioAdvance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|